eVisit acquires UPMC’s Inpatient Teleconsult Technology and secures investments from UPMC Enterprises and MedStar Health

July 10, 2024- eVisit, the leading enterprise virtual care transformation partner for innovative health systems, announced the acquisition of UPMC’s inpatient teleconsult technology alongside strategic direct investments by UPMC Enterprises and MedStar Health, adding to its $45 million Series B fundraising led by Goldman Sachs Asset Management. The organizations will also respectively pursue co-development opportunities with eVisit and have representatives join eVisit’s Clinical Advisory Board.

UPMC Technology Acquisition and New Collaborations

UPMC Enterprises, the innovation, commercialization, and venture capital arm of UPMC, is entering an agreement for eVisit to acquire its inpatient teleconsult technology platform. The acquisition will considerably expand eVisit’s inpatient telehealth capabilities in facilitating quick, expert care, advancing its leadership in serving health systems across ambulatory and inpatient care settings.

Developed by UPMC in 2020, during the initial stages of the COVID-19 pandemic, the teleconsult technology enables virtual clinical specialists to efficiently consult with bedside clinicians about inpatient care across five services: stroke, neurology, critical care, psychology, and toxicology. This teleconsult technology brings world-class clinical care to patients in even the most remote rural hospitals. Since its inception, 40,000 consults have been delivered via the teleconsult technology platform, resulting in a 92% decrease in wait times.

UPMC Enterprises Technology Services will also provide technology advisory expertise to eVisit. Andrew R. Watson, MD, UPMC Enterprises senior medical advisor and past president of the American Telemedicine Association, will join eVisit’s Clinical Advisory Board.

Learn More

safe online pharmacy for viagra cheap kamagra oral jelly online